Efficacy, Safety, and Immunogenicity of V260 in Healthy Chinese Infants (V260-024)

Clinical trial NCT02062385 · COMPLETED

Trial details

NCT number: NCT02062385
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rotavirus Gastroenteritis

Start date: 2014-05-30
Primary completion: 2015-06-11
Enrollment: 4040

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.